Russia to vaccinate high risk groups against Covid-19 towards end of year - agencies
Russia this month became the first country to grant regulatory approval to a Covid-19 vaccine after less than two months of human testing, prompting international experts to question its safety and efficacy
A handout photo provided by the Russian Direct Investment Fund (RDIF) shows samples of a vaccine against the coronavirus disease (Covid-19) developed by the Gamaleya Research Institute of Epidemiology and Microbiology, in Moscow, Russia August 6, 2020. Picture taken August 6, 2020. The Russian Direct Investment Fund (RDIF)/Handout via REUTERS
Russian Health Minister Mikhail Murashko said on Monday that mass vaccination of high risk groups in the country against Covid-19 would begin in November-December this year, Russian news agencies reported.
Russia this month became the first country to grant regulatory approval to a Covid-19 vaccine after less than two months of human testing, prompting international experts to question its safety and efficacy.
Keep updated, follow The Business Standard's Google news channel
